Proteasome Enzymatic Activities in Plasma as Risk Stratification of Patients with Acute Myeloid Leukemia and Advanced Myelodysplastic Syndrome

PURPOSE: Cytogenetic abnormalities are currently the most important predictors of response and clinical outcome for patients with acute myeloid leukemia (AML) or advanced-stage myelodysplastic syndrome (MDS). Because clinical outcomes vary markedly within cytogenetic subgroups, additional biological...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ma, Wanlong, Kantarjian, Hagop, Bekele, Benjamin, Donahue, Amber C, Zhang, Xi, Zhang, Zhong J, O'Brien, Susan, Estey, Elihu, Estrov, Zeev, Cortes, Jorge, Keating, Michael, Giles, Francis, Albitar, Maher
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4091712/
https://ncbi.nlm.nih.gov/pubmed/19458051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-3034
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados